Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham is a clinical research site located in Birmingham, Alabama, United States 35294.
Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.
Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham has participated in 30 clinical trials.
Therapeutic areas: Lung Cancer, Sarcoma, Leukemia.
Sponsors: Radiation Therapy Oncology Group, Children's Oncology Group, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
Trust Score: 83/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham has 30 clinical trials on record. Their work covers Lung Cancer, Sarcoma, Leukemia.
Yes — Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.